Serial #79404681
LIVE

Serial Number

79404681

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79404681 Trademark

Serial Number: 79404681 • Registration: 7764678

Serial #79404681 is a trademark filed by NOVARTIS AG on May 23, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,170 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 23, 2024

Registration Date

April 22, 2025

Published for Opposition

March 4, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 5, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 18, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 18, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2025 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 12, 2025 FICS
FINAL DISPOSITION PROCESSED
Nov 12, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 23, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 22, 2025 R.PR
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 5, 2025 CNSA
REFUSAL PROCESSED BY IB
Jan 10, 2025 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 23, 2024 RFCS
REFUSAL PROCESSED BY MPU
Dec 23, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 12, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 11, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Oct 11, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 11, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 11, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 11, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 11, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Sep 27, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 24, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 19, 2024 REPR